Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | We listened your feedback for Transdermal and Microneedle Drug Delivery ConferenceSAE Media Group reports: In 2023 the conference has built upon and improved on speakers and topics based on customer feedback
By: SAE Media Group Vaccine delivery will be a significant aspect of this year's agenda with a focus on microneedle delivery technologies as a mode for vaccine delivery, in the pursuit to increase vaccine stability and accessibility. An outlook of the transdermal space will also be reviewed, including future directions and next steps required to advance the current field and accelerate access for patients and end users. Find out more about the key topics discussed online at: www.transdermal- The two-day agenda offers you peer-to-peer networking with CEO's, Senior Vice presidents, Directors of Delivery Technologies, Heads of Product Development and many more. Delegates attending will have the opportunity to: Engage with senior industry opinion leaders presenting their experiences and case studies in innovative device design and advanced drug product formulation Gain insights from notified body and competent authority representatives addressing key regulatory requirements Understand how to optimize your lifecycle management strategy for a commercially successful device Explore and benchmark against industry advances in device design through case studies and real-world examples To view the full agenda and speaker line-up please visit the website at: www.transdermal- Contact Information: For Sponsorship Packages Please Contact Daniele Moreschi on +44 (0)20 7827 6050 Or dmoreschi@smi- For Delegate Enquiries, Contact Jamie Wilkinson on +44 (0) 20 7827 6136 Or jwilkinson@smi- For media enquiries contact Richard Jones on +44 (0)20 7827 6088 or rjones@smi-online.co.uk Transdermal and Microneedle Drug Delivery conference 24 - 24 January 2023 London, UK www.transdermal- @SAEMGPharma #SAETransdermal End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|